Previous close | 16.00 |
Open | 16.00 |
Bid | 18.00 |
Ask | 22.00 |
Strike | 85.00 |
Expiry date | 2024-10-18 |
Day's range | 16.00 - 16.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Esperion's (ESPR) first-quarter earnings and sales beat estimates on the back of better-than-expected collaboration revenues.
Intra-Cellular (ITCI) reports first-quarter 2024 results, wherein both earnings and revenues beat estimates, driven by strong Caplyta sales.
Pacira (PCRX) reports first-quarter 2024 results, wherein earnings miss but revenues beat estimates, driven by Exparel sales.